Vascular Closure Devices Market

Vascular Closure Devices Market by Type (Passive Approximators (Collagen Plugs Sealent/Gel Based), Active Approximators (Clip, Suture Devices)), Access (Femoral,Radial) & Procedure (Interventional Cardiology, Radiology) - Global Forecasts to 2022

Report Code: MD 5243 May, 2017, by marketsandmarkets.com

[128 Pages Report] The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for this market include the large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices.

The report provides an overall understanding of the market. In this report, the market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segments, the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

Geographic analysis reveals that the North American segment is expected to account for the largest share of the market in 2017, owing to the increasing prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and the increasing number of research and clinical trials for vascular closure devices.

The major players in this market are Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), and  Cardiva Medical Inc. (U.S.).

Target Audience for this Report:

  • Vendors/service providers
  • Research institutes
  • Contract research organizations (CROs)
  • Contract manufacturing organizations (CMOs)
  • Interventional cardiology vascular device manufacturers
  • Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
  • Niche companies manufacturing novel vascular closure devices
  • Research and consulting firms

Scope of the Report

To know about the assumptions considered for the study, download the pdf brochure

This research report categorizes the global market into the following segments and subsegments:

Vascular Closure Devices Market, by Type

  • Passive Approximators
  • Collagen Plugs
  • Sealant- or Gel-based Devices
  • Compression-assist Devices
  • Active Approximators
  • Suture-based Devices
  • Clip-based Devices
  • External Hemostatic Devices

Vascular Closure Devices Market, by Access

  • Femoral
  • Radial

Vascular Closure Devices Market, by Procedure

  • Interventional Cardiology
  • Interventional Radiology/Vascular Surgery

Vascular Closure Devices Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe (RoE)
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the rest of Europe segment into France, Finland, Sweden, and Switzerland

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

The Passive Approximators segment to grow at the highest CAGR during the forecast period

On the basis of type, the global vascular closure device market is segmented into passive approximators, active approximators, and external hemostatic devices. In 2017, passive approximators segment accounted for the largest share of ~ 67% of the global vascular closure device market. The passive approximators consist of a plug, sealant, or a gel that can be deployed at the arteriotomy site to passively close the femoral artery. The passive approximators segment is further divided into collagen plugs, sealant or gel-based devices, and compression assist devices. The large share of this market can be attributed to the large number of approvals for vascular closure devices and the high prevalence of cardiovascular disease and obesity. However, the high cost of vascular closure devices and the increasing popularity of interventional procedures using radial arteries are likely to limit market growth to a certain extent.

The global vascular closure devices market is expected to reach USD 984.6 million by 2022. The key factors propelling the growth of the the vascular closure devices market are the rising prevalence of cardiovascular diseases, increase in obese population, increasing number of regulatory approvals, and increasing focus of market players on large-bore vascular closure devices.

The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market

Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits.

Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods. Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings.

Additionally, malfunctioning of devices, poor quality, and underperformance of devices are the primary causes of product recalls. Product failures and recalls cost companies millions of dollars in product replacements and lost revenues. They may also create a negative impression about the product, which in turn may limit the adoption of these products.

However, growth in target markets in emerging nations such as China, India, and Brazil, offer significant growth opportunities for players operating in the vascular closure devices market.

Market Dynamics

Vascular Closure Device Market

The benefits of interventional cardiology procedures including reduced scarring and less pain due to their minimally invasive nature are driving the interventional cardiology market from vascular closure devices.

Interventional cardiologists use vascular closure devices to close the artery after the procedure. Interventional cardiology deals specifically with catheter-based treatment of structural heart diseases. These procedures are done through blood vessels like the transfemoral or transradial artery for angioplasty and stenting. Market players offer on-hand practice to surgeons, physicians, and cardiologists for their vascular closure devices. This ensures safety, efficiency, and the effective deployment of these devices during cardiac procedures.

CVDs are the leading cause of death worldwide. This figure for deaths caused due to CVDs is expected to increase to 23.6 million by 2030 (Source: World Health Organization). The significant growth in the incidence of CVDs is resulting in an increase in the demand for cardiac interventional procedures.

A large number of active approximators provided by market players that can close large bore arteries is mainly driving the market for active approximators, while the high cost of vascular closure devices and growing preference for radial artery procedures are restricting the growth of this segment

Suture-Based Devices

Suture-based devices deploy a suture on either side of the arteriotomy. These devices mediate the ligation of the artery with the help of needles and sutures. This enables hemostasis of the arterial site, and the tails of the suture are trimmed from the surface of the skin.

Suture-based devices are essentially used to close large bores of 5-21 F in the artery site. With suture-based devices, physical closure of the arteriotomy site can be achieved, re-access to the site can be done easily, and anticoagulation is not required. These devices can be used to close both large and small arteriotomy sites safely.

Perclose A-T, Perclose, Prostar XL, and Perclose ProGlide by Abbott Vascular (U.S.) are used for artery closure for sizes ranging from 5F to 21F. Moreover, new players have introduced new and advanced suture-based devices, in 2016, for Vascular Sealing System (VSS) products.

Clip-Based Devices

Clip-based devices are made up of nitinol clips, a nickel-titanium alloy with superelastic properties, which are small, circumferential, and flexible. Owing to its superelastic nature, the clip mechanically binds to the surface of the arteriotomy site. This enables the clip to achieve hemostasis and prevents potential blockages.

The main advantage of these devices is that after the procedure, the device is completely removed from the body and leaves nothing on the inside of the lumen as compared to other devices. The nitinol metal chip remains on the surface of the artery site that can be visualized in an MRI procedure. Since the clip is placed on the surface of the artery, arterial blockage is avoided. However, the clip limits the evaluation of the immediately adjacent structures of the artery site when visualized with MRI. Moreover, misplacement of the nitinol clip on the intravascular site at the time of vascular closure procedures can lead to complications, which can cause femoral artery laceration and increased risk of infection on the site and stenosis.

The introduction of new clip based products such as the nitinol clip will additionally help boost this market.

Key Questions

  • What will be the impact on utilization of closure devices and the provision of cardiac surgeries?
  • What will be the impact of government initiatives on the sale of vascular closure devices?

The global vascular closure devices market is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for the market include a large number of approvals for vascular closure devices, increasing focus of market players on large-bore vascular closure devices, the high prevalence of cardiovascular diseases, and high prevalence of obesity. On the other hand, the high cost of vascular closure devices, product recalls and failures, and increasing preference for interventional procedures using radial artery access are limiting the growth of the global market to a certain extent.

In this report, the market has been segmented based on type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Passive approximators are expected to account for the largest share of the market in 2017. Passive approximators are the most widely used vascular closure devices in the market owing to the wide range of advantages associated with them, including increased safety and fewer complications than manual procedures.

The access segment includes femoral access and radial access. The femoral access segment is estimated to account for the largest share of the market in 2017 owing to the widespread preference for this access route among cardiologists and physicians during interventional procedures as well as the fewer complications involved during arterial access.

The procedures segment of the vascular closure devices market includes interventional cardiology and interventional radiology/vascular surgery. The interventional cardiology segment is expected to hold the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases and increasing obese population across the globe.

The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S., growing trend of one-day surgery for vascular procedures, and increasing research and clinical trials for vascular closure devices.

Vascular Closure Device Market

The major players in this market include Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd. (Ireland).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions of the Study

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 29)
    4.1 Vascular Closure Devices: Market Overview
    4.2 Geographic Analysis: Global Market, By Type (2017)
    4.3 Market, By Access, 2017 vs 2022
    4.4 Market, By Procedure, 2017 vs 2022
    4.5 Geographic Snapshot of the Global Market

5 Market Overview (Page No. - 33)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Large Number of Approvals for Vascular Closure Devices
                    5.2.1.2 High Prevalence of Cardiovascular Diseases
                    5.2.1.3 Increasing Prevalence of Obesity
                    5.2.1.4 Increasing Focus of Market Players on Large-Bore Vascular Closure Devices
           5.2.2 Restraints
                    5.2.2.1 Increasing Preference for Interventional Procedures Using Radial Artery Access
                    5.2.2.2 High Cost of Vascular Closure Devices
                    5.2.2.3 Product Recalls and Failures
           5.2.3 Opportunity
                    5.2.3.1 Emerging Markets Providing Growth Opportunities for Market Players
           5.2.4 Challenges
                    5.2.4.1 Need for Highly Skilled Professionals
                    5.2.4.2 Risks Associated With Vascular Closure Devices

6 Global Vascular Closure Devices Market, By Type (Page No. - 39)
    6.1 Introduction
    6.2 Passive Approximators
           6.2.1 Collagen Plugs
           6.2.2 Sealant Or Gel-Based Devices
           6.2.3 Compression Assist Devices
    6.3 Active Approximators
           6.3.1 Suture-Based Devices
           6.3.2 Clip-Based Devices
    6.4 External Hemostatic Devices

7 Global Vascular Closure Devices Market, By Access (Page No. - 48)
    7.1 Introduction
    7.2 Femoral Access
    7.3 Radial Access

8 Global Vascular Closure Devices Market, By Procedure (Page No. - 53)
    8.1 Introduction
    8.2 Interventional Cardiology
    8.3 Interventional Radiology/Vascular Surgery

9 Global Vascular Closure Devices Market, By Region (Page No. - 57)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
                    9.2.1.1 Rising Prevalence of Cardiovascular Diseases
                    9.2.1.2 Growing Trend of One-Day Surgeries for Vascular Procedures
                    9.2.1.3 Increase in Research and Clinical Trials for Vascular Closure Devices
                    9.2.1.4 Increasing Number of Conferences, Meetings, Symposia, and Workshops
           9.2.2 Canada
                    9.2.2.1 Increasing Number of Cardiac Arrest Cases
                    9.2.2.2 Long Waiting Times for Cardiac Surgery Likely to Encourage the Adoption of Minimally Invasive Procedures
    9.3 Europe
           9.3.1 Increasing Focus of Market Players in the European Region
           9.3.2 E-3
                    9.3.2.1 Increasing Number of Research Studies on Vascular Closure Devices in Germany
                    9.3.2.2 Rising Prevalence of CVDS in Germany
                    9.3.2.3 Increase in the Number of Radial Access Procedures in France and the U.K.
                    9.3.2.4 Growth in the Aging and Obese Populations in the U.K.
           9.3.3 RoE
    9.4 Asia-Pacific
           9.4.1 Rapid Growth in the Aging Population in Japan & China
           9.4.2 Cost—A Major Concern for Interventional Procedures in India
           9.4.3 Healthcare Reforms, Government Initiatives, and Investments in China and Japan
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 85)
     10.1 Introduction
     10.2 Vendor Dive Overview
             10.2.1 Vanguards
             10.2.2 Innovators
             10.2.3 Emerging Players
             10.2.4 Dynamic Players
     10.3 Competitive Benchmarking
             10.3.1 Analysis of the Product Portfolio of Major Players in the Market (23 Companies)
             10.3.2 Business Strategies Adopted By Major Players in the Market (23 Companies)

*Top 23 Companies Analyzed for This Study are - Tz Medical, Inc. (U.S.), Vasorum Ltd. (Ireland), Inseal Medical Ltd. (Israel), Morris Innovative Inc. (U.S.), Essential Medical Inc. (U.S.), Arstasis Inc. (U.S.), Tricol Medical Inc. (U.S.), Marine Polymer Technologies (U.S.), Hemostasis LLC (U.S.), Chitogen Inc. (U.S.), Endocor GmbH (Germany), Transluminal Technologies LLC (U.S.), Hemoband Corporation (U.S.), Vascualr Closure Systems Inc. (U.S.), Advanced Vascular Dynamics (U.S.), Scion Biomedical (U.S.), Terumo Corporation (Japan), Abbott Laboratories (U.S.), Cardinal Health, Inc. (U.S.), Cardiva Medical, Inc.(U.S.), Medtronic PLC (Ireland), Merit Medical Systems Inc. (U.S.), Vivasure Medical Ltd. (Ireland)

11 Company Profiles (Page No. - 89)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     11.1 Terumo Corporation
     11.2 Abbott Laboratories
     11.3 Cardinal Health, Inc. (Cordis)
     11.4 Cardiva Medical, Inc.
     11.5 Medtronic PLC 
     11.6 Morris Innovative, Inc.
     11.7 Essential Medical, Inc.
     11.8 Merit Medical Systems, Inc.
     11.9 Vasorum Ltd.
     11.10 TZ Medical, Inc.
     11.11 Vivasure Medical Ltd.
     11.12 Inseal Medical Ltd.
     11.13 Tricol Biomedical, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 120)
     12.1 Discussion Guide
     12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.3 Introducing RT: Real-Time Market Intelligence
     12.4 Available Customizations
     12.5 Related Reports
     12.6 Author Details


List of Tables (61 Tables)

Table 1 Global Vascular Closure Devices Market, By Type, 2015–2022 (USD Million)
Table 2 Market for Passive Approximators, By Region, 2015–2022 (USD Million)
Table 3 Market for Passive Approximators, By Type, 2015–2022 (USD Million)
Table 4 Collagen Plugs Market, By Region, 2015–2022 (USD Million)
Table 5 Sealant Or Gel-Based Devices Market, By Region, 2015–2022 (USD Million)
Table 6 Compression Assist Devices Market, By Region, 2015–2022 (USD Million)
Table 7 Market for Active Approximators, By Region, 2015–2022 (USD Million)
Table 8 Market for Active Approximators, By Type, 2015–2022 (USD Million)
Table 9 Suture-Based Devices Market Size, By Region, 2015–2022 (USD Million)
Table 10 Clip-Based Devices Market Size, By Region, 2015–2022 (USD Million)
Table 11 Vascular Closure Devices Market for External Hemostatic Devices, By Region, 2015–2022 (USD Million)
Table 12 Market Size, By Access, 2015–2022 (USD Million)
Table 13 Market Size for Femoral Access, By Region, 2015–2022 (USD Million)
Table 14 Market Size for Radial Access, By Region, 2015–2022 (USD Million)
Table 15 Market Size, By Procedure, 2015–2022 (USD Million)
Table 16 Market Size for Interventional Cardiology, By Region, 2015–2022 (USD Million)
Table 17 Market Size for Interventional Radiology/Vascular Surgery, By Region, 2015–2022 (USD Million)
Table 18 Market Size, By Region, 2015-2022 (USD Million)
Table 19 North America: Vascular Closure Devices Market Size, By Country, 2015-2022 (USD Million)
Table 20 North America: Market Size, By Type, 2015-2022 (USD Million)
Table 21 North America: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 22 North America: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 23 North America: Market Size, By Access, 2015-2022 (USD Million)
Table 24 North America: Market Size, By Procedure, 2015-2022 (USD Million)
Table 25 Indicative List of Recent Conferences/Meetings/Symposia/Workshops Held in the U.S.
Table 26 U.S.: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 27 U.S.: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 28 U.S.: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 29 U.S.: Market Size, By Access, 2015-2022 (USD Million)
Table 30 U.S.: Market Size, By Procedure, 2015-2022 (USD Million)
Table 31 Canada: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 32 Canada: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 33 Canada: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 34 Canada: Market Size, By Access, 2015-2022 (USD Million)
Table 35 Canada: Market Size, By Procedure, 2015-2022 (USD Million)
Table 36 Europe: Vascular Closure Devices Market Size, By Region, 2015-2022 (USD Million)
Table 37 Europe: Market Size, By Type, 2015-2022 (USD Million)
Table 38 Europe: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 39 Europe: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 40 Europe: Market Size, By Access, 2015-2022 (USD Million)
Table 41 Europe: Market Size, By Procedure, 2015-2022 (USD Million)
Table 42 E-3: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 43 E-3: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 44 E-3: Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 45 E-3: Market Size, By Access, 2015-2022 (USD Million)
Table 46 E-3: Market Size, By Procedure, 2015-2022 (USD Million)
Table 47 RoE: Vascular Closure Devices Market Size, By Type, 2015-2022 (USD Million)
Table 48 RoE: Passive Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 49 RoE: Vascular Closure Active Approximators Market Size, By Type, 2015-2022 (USD Million)
Table 50 RoE: Market Size, By Access, 2015-2022 (USD Million)
Table 51 RoE: Market Size, By Procedure, 2015-2022 (USD Million)
Table 52 Asia-Pacific: Vascular Closure Devices Market Size, By Type, 2015–2022 (USD Million)
Table 53 Asia-Pacific: Passive Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 54 Asia-Pacific: Active Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 55 Asia-Pacific: Market Size, By Access, 2015–2022 (USD Million)
Table 56 Asia-Pacific: Market Size, By Procedure, 2015–2022 (USD Million)
Table 57 RoW: Vascular Closure Devices Market Size, By Type, 2015–2022 (USD Million)
Table 58 RoW: Passive Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 59 RoW: Active Approximators Market Size, By Type, 2015–2022 (USD Million)
Table 60 RoW: Market Size, By Access, 2015–2022 (USD Million)
Table 61 RoW: Market Size, By Procedure, 2015–2022 (USD Million)
 
 
List of Figures (30 Figures)
 
Figure 1 Research Methodology: Global Vascular Closure Devices
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design: Global Vascular Closure Devices
Figure 6 Data Triangulation Methodology
Figure 7 Global Vascular Closure Devices Market, By Type (2017)
Figure 8 Global Market Size, By Access, 2017 vs 2022 (USD Million)
Figure 9 Global Market, By Procedure, 2017 vs 2022 (USD Million)
Figure 10 Geographical Snapshot of the Market
Figure 11 Rising Prevalence of Cardiovascular Diseases & Increasing Number of Regulatory Approvals are Major Factors Driving the Growth of the Market
Figure 12 Passive Approximators Segment to Account for the Largest Market Share in 2017
Figure 13 Femoral Access Segment Will Continue to Dominate the Global Market in 2022
Figure 14 Interventional Cardiology Segment to Account for the Largest Market Share in 2017
Figure 15 North America to Register the Highest CAGR in the Forecast Period
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Passive Approximators to Command the Largest Share and Register the Highest CAGR in the Global Vascular Closure Devices Market
Figure 18 Femoral Access Segment to Account for the Largest Share of the Vascular Closure Devices Market, By Access, in 2017
Figure 19 Interventional Cardiology Segment to Account for the Largest Share of the Market, By Procedure, in 2017
Figure 20 North America to Dominate the Market in 2017
Figure 21 North America: Market Snapshot
Figure 22 Europe: Market Snapshot
Figure 23 Asia-Pacific: Market Snapshot
Figure 24 RoW: Market Snapshot
Figure 25 MnM Dive - Vendor Comparison Chart
Figure 26 Terumo Corporation: Company Snapshot (2015)
Figure 27 Abbott Laboratories: Company Snapshot (2016)
Figure 28 Cardinal Health, Inc. Company Snapshot (2016)
Figure 29 Medtronic PLC: Company Snapshot (2016)
Figure 30 Merit Medical Systems, Inc.: Company Snapshot (2015)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 5243
Published ON
May, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Vascular Closure Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved